Abstract: This invention provides the controlled-release method for a pharmaceutical composition comprising of metals in the drug carrier. The specific chelator is used to trigger the release of active pharmaceutical ingredients from chelating complex micelles. The drug release rate and half-life can also be controlled by manipulating the dosing sequence and the concentration of metal and specific chelator.

Abstract: A respiratory function testing system includes an air transforming device, a sound reception device and an operation device. The air transforming device is configured to collect exhaled air for a predetermined period and generate a full-range sound signal according to the collected exhaled air. The full-range sound signal at least contains an ultrasonic signal. The sound reception device is configured to receive and record the full-range sound signal. The operation device is in communication with the sound reception device and is configured to receive and compute the ultrasonic signal contained in the full-range sound signal recorded by the sound reception device to generate a respiratory function parameter. A respiratory function testing method of the respiratory function testing system is also provided.

Abstract: A cell module includes an ion exchange membrane, a first electrode, a second electrode, a first current collector plate, and a second current collector plate. The first electrode and the second electrode are disposed at two sides of the ion exchange membrane, wherein a sensing element is disposed in the first electrode, and the first electrode includes an insulating frame. The first current collector plate is located at one side of the first electrode, and the second current collector plate is located at one side of the second electrode.

Abstract: A power bypass apparatus includes a bypass switch circuit and a selection structure. The selection structure is electrically connected to the bypass switch circuit. A power supply apparatus sends a power through the bypass switch circuit to a power output side of a power transmission unit selected and connected by the selection structure when the bypass switch circuit is turned on.

Abstract: A membrane-electrode assembly for water electrolysis including a proton-exchange membrane, a first catalyst layer, a second catalyst layer, a first gas diffusion layer, a second gas diffusion layer and a first sensor chip. The proton-exchange membrane is disposed between an inner side of the first catalyst layer and an inner side of the second catalyst layer. The first gas diffusion layer is disposed on an outer side of the first catalyst layer. The second gas diffusion layer is disposed on an outer side of the second catalyst layer. The first sensor chip is sandwiched between the first catalyst layer and the first gas diffusion layer to sense an environmental change where water electrolysis takes place.

Abstract: A method of numerical-control scraping of a work piece has a preparing step, a scanning step, a flatness-parameter inputting step, a surface-finishing step, a related-parameter inputting step, an auto-scraping step and an analyzing step. The preparing step comprises preparing a multi-axis machine tool, a laser displacement meter, an auto scraping apparatus and a computer. The scanning step comprises scanning the work piece. The flatness-parameter inputting step comprises inputting a flatness-parameter. The surface-finishing step comprises calculating out the to-be-scraped ranges of the work piece and scraping the work piece. The related-parameter inputting step comprises inputting desired PPI and POP in the computer, calculating out the HOP, the DOS and the oil content to obtain the length, the width and the depth of a single scraping process. The auto-scraping step comprises scraping the work piece to meet the requirement. The analyzing step comprises detecting the 3D-appearance drawing of the work piece.

Abstract: This invention provides Chelating Complex Micelles as a drug carrier. The Chelating Complex Micelles can load drugs without changing their structure, and therefore extend the half-life of drugs in the human body. The chelating complex micelles contain a metal ion core, at least one polymer, and at least one drug molecule. The metal ion is considered as a Lewis acid while polymer chain and drug molecules are referred to as Lewis bases. The drug molecule is linked to the polymer via forming coordinate bonds with metal ion, and then self-assembled to form chelating complex micelles as a drug carrier.

Abstract: A flow battery stack includes a cell and two end plates, and the end plates are respectively disposed at two sides of the cell. The cell includes a membrane electrode assembly (MEA), a sensing chip, and a flow guide plate. The sensing chip has a frame part and a sensing part, and the sensing part connects to the frame part. The frame part is disposed between the MEA and the flow guide plate, and the sensing part extends to a flow region of the flow guide plate so as to sense the temperature or the flow capacity of a liquid in the flow region.

Abstract: This invention provides Chelating Complex Micelles as a drug carrier. The Chelating Complex Micelles can load drugs without changing their structure, and therefore extend the half-life of drugs in the human body. The chelating complex micelles contain a metal ion core, at least one polymer, and at least one drug molecule. The metal ion is considered as a Lewis acid while polymer chain and drug molecules are referred to as Lewis bases. The drug molecule is linked to the polymer via forming coordinate bonds with metal ion, and then self-assembled to form chelating complex micelles as a drug carrier.

Abstract: This invention provides Chelating Complex Micelles as a drug carrier. The Chelating Complex Micelles can load drugs without changing their structure, and therefore extend the half-life of drugs in the human body. The chelating complex micelles contain a metal ion core, at least one polymer, and at least one drug molecule. The metal ion is considered as a Lewis acid while polymer chain and drug molecules are referred to as Lewis bases. The drug molecule is linked to the polymer via forming coordinate bonds with metal ion, and then self-assembled to form chelating complex micelles as a drug carrier.

Abstract: There is disclosed a display method of a display device and the display device for implementing the display method. The display method includes: frequency-doubling converting a display signal when the display device determines that a scanning frequency of the display signal inputted to the display device is lower than a set threshold; and outputting the frequency-doubling converted display signal. The display output effect of the display device can be improved with the technical solutions of the present disclosure, so as to enhance user's experience.

Abstract: The present invention features a pharmaceutical composition used for reducing the damage caused by free radicals, which comprises at least a metal or its ions, at least a drug or an antioxidant that is carrier-protected/modified, and a drug carrier. Said carrier helps to preserve the anti-oxidative activity, and hence, prevents the decrease of the effect of the antioxidant against free radicals produced in the environment or body fluids and prolongs protection, and may be used for reducing damage caused by radiation and adverse effects induced by chemotherapeutic drugs.

Abstract: A conductive winding assembly combining a bent conduction sheet member and a covering member is provided. The bent conduction sheet member has a channel. The covering member includes a connection part, a first lateral plate, a second lateral plate, and a hollow part. A first groove is arranged between the first lateral plate and the connection part. A second groove is arranged between the second lateral plate and the connection part. The bent conduction sheet member is inserted into the covering member through the first groove and the second groove, and the connection part is inserted into the channel. The bent conduction sheet member is partially accommodated within the hollow part, and the bent conduction sheet member is partially exposed outside the covering member through the hollow part.

Abstract: A conductive winding assembly combining a bent conduction sheet member and a covering member is provided. The bent conduction sheet member has a channel. The covering member includes a connection part, a first lateral plate, a second lateral plate, and a hollow part. A first groove is arranged between the first lateral plate and the connection part. A second groove is arranged between the second lateral plate and the connection part. The bent conduction sheet member is inserted into the covering member through the first groove and the second groove, and the connection part is inserted into the channel. The bent conduction sheet member is partially accommodated within the hollow part, and the bent conduction sheet member is partially exposed outside the covering member through the hollow part.

Abstract: A pixel structure including a substrate, an active device located on the substrate, a second reflective pattern, and a third reflective pattern is provided. The active device includes a gate, a channel, a source, and a drain. The source and the drain are connected to the channel and are separated from each other. The channel and the gate are stacked in a thickness direction. The second reflective pattern and the third reflective pattern are electrically connected to the drain of the active device. The second reflective pattern has second contact openings. The third reflective pattern is stacked on the second reflective pattern and covers the second contact openings of the second reflective pattern. The second reflective pattern is located between the third reflective pattern and the substrate. Moreover, other kinds of pixel structures are also provided.

Abstract: This invention provides Chelating Complex Micelles as a drug carrier. The Chelating Complex Micelles can load drugs without changing their structure, and therefore extend the half-life of drugs in the human body. The chelating complex micelles contain a metal ion core, at least one polymer, and at least one drug molecule. The metal ion is considered as a Lewis acid while polymer chain and drug molecules are referred to as Lewis bases. The drug molecule is linked to the polymer via forming coordinate bonds with metal ion, and then self-assembled to form chelating complex micelles as a drug carrier.

Abstract: This invention provides Chelating Complex Micelles as a drug carrier. The Chelating Complex Micelles can load drugs without changing their structure, and therefore extend the half-life of drugs in the human body. The chelating complex micelles contain a metal ion core, at least one polymer, and at least one drug molecule. The metal ion is considered as a Lewis acid while polymer chain and drug molecules are referred to as Lewis bases. The drug molecule is linked to the polymer via forming coordinate bonds with metal ion, and then self-assembled to form chelating complex micelles as a drug carrier.

Abstract: This invention provides Chelating Complex Micelles as a drug carrier. The Chelating Complex Micelles can load drugs without changing their structure, and therefore extend the half-life of drugs in the human body. The chelating complex micelles contain a metal ion core, at least one polymer, and at least one drug molecule. The metal ion is considered as a Lewis acid while polymer chain and drug molecules are referred to as Lewis bases. The drug molecule is linked to the polymer via forming coordinate bonds with metal ion, and then self-assembled to form chelating complex micelles as a drug carrier.

Abstract: A magnetic mechanism is disclosed, which includes a bobbing, a first and a second magnetic core and a winding coil. The bobbing includes a main body and a base member. The first and second magnetic cores are disposed on two opposite sides of the main body, and the winding coil is wound on a wire-winding portion of the main body and is threaded through a guiding hole of the base, wherein the guiding hole is away from the wire-winding portion in comparison with the outer most edge of the main body.

Abstract: This invention provides the controlled-release method for a pharmaceutical composition comprising of metals in the drug carrier. The specific chelator is used to trigger the release of active pharmaceutical ingredients from chelating complex micelles. The drug release rate and half-life can also be controlled by manipulating the dosing sequence and the concentration of metal and specific chelator.